Evidence map›Paper›PMID 39081698›Full record

ReviewCancer management and research2024

Zhenyu Li, Jimin Liu, Haishan Cui, Wenlong Qi, Yangyang Tong, Tan Wang

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Cancer management and research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Zhenyu LiCollege of Traditional Chinese Medicine, Changchun University of Chinese Medicine, Changchun, 130117, People's Republic of China.
Jimin LiuDepartment of Respiratory, The Third Affiliated Hospital to Changchun University of Chinese Medicine, Changchun, 130117, People's Republic of China.
Haishan CuiDepartment of Traditional Chinese Medicine, The Third Affiliated Hospital to Changchun University of Chinese Medicine, Changchun, 130117, People's Republic of China.
Wenlong QiDepartment of Respiratory, The Affiliated Hospital to Changchun University of Chinese Medicine, Changchun, 130021, People's Republic of China.
Yangyang TongDepartment of Respiratory, The Affiliated Hospital to Changchun University of Chinese Medicine, Changchun, 130021, People's Republic of China.
Tan WangDepartment of Respiratory, The Affiliated Hospital to Changchun University of Chinese Medicine, Changchun, 130021, People's Republic of China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The rising global morbidity and mortality rates of non-small cell lung cancer (NSCLC) underscore the urgent need for more effective treatments. Current therapeutic modalities-including surgery, radiotherapy, chemotherapy, and targeted therapy-face several limitations. Recently,

Indexed as

antitumor activityAstragalus membranaceuscisplatinimmunoregulationnon-small cell lung cancer

Identifiers

PMID39081698
PMCPMC11287463

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.